HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Biotechnology in Drug Delivery

Biotechnology in Drug Delivery

Biotechnology in drug delivery represents a revolutionary field that harnesses biological processes and techniques to enhance the targeted and efficient delivery of pharmaceutical compounds. This cutting-edge approach seeks to overcome traditional challenges in drug delivery, such as limited specificity and potential side effects. Through the integration of biotechnological tools, researchers can design advanced drug delivery systems that optimize therapeutic outcomes while minimizing adverse effects. One key aspect of biotechnology in drug delivery involves the development of innovative drug carriers, often utilizing biomaterials or nanoparticles. These carriers can be engineered to encapsulate drugs, protecting them from degradation and facilitating their release at specific sites within the body. Furthermore, biotechnological advancements enable the customization of drug delivery systems based on the unique characteristics of diseases or individual patients. Biotechnology also plays a crucial role in designing drug formulations that respond dynamically to physiological changes. Smart drug delivery systems, guided by biological signals, allow for on-demand release of therapeutic agents, maximizing efficacy while minimizing systemic exposure. This level of precision is particularly valuable in the treatment of complex diseases, including cancers and chronic conditions. Moreover, biotechnological interventions contribute to the development of personalized medicine approaches. By leveraging genetic information and molecular targeting, drug delivery systems can be tailored to the genetic makeup of patients, increasing treatment effectiveness and reducing the risk of adverse reactions. In conclusion, biotechnology in drug delivery is revolutionizing the pharmaceutical landscape by offering solutions that enhance drug efficacy, minimize side effects, and pave the way for personalized therapeutic interventions. As this field continues to evolve, it holds the promise of transforming the way we approach and administer treatments, ultimately improving patient outcomes and quality of life.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Thomas J Webster

Thomas J Webster

Brown University, United States
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
ECBB 2026 Speakers
Speaker at Biotechnology and Bioengineering 2026 - K R Aneja

K R Aneja

Kurukshetra University, India
Speaker at Biotechnology and Bioengineering 2026 - Gunjan Mukherjee

Gunjan Mukherjee

Chandigarh University, India
Speaker at Biotechnology and Bioengineering 2026 - Md Monir Hossain

Md Monir Hossain

RMIT University, Australia
Speaker at Biotechnology and Bioengineering 2026 - Tamer Z Salem

Tamer Z Salem

Zewail City of Science and Technology, Egypt
Tags

Submit your abstract Today

Watsapp